A Case Report on Etoricoxib Induced Stevens Johnson Syndrome

Published on:January 2021
Indian Journal of Pharmacy Practice, 2021; 14(1):65-67
Case Report | doi:10.5530/ijopp.14.1.13

A Case Report on Etoricoxib Induced Stevens Johnson Syndrome

Authors and affiliation (s):

Poludasari Shravan Kumar*, Bomma Tharuni

Department of Pharmacy Practice, Malla Reddy Pharmacy College, Maisammaguda, Secunderabad, Telangana, INDIA.


Etoricoxib is a selective cyclo-oxygenase enzyme-2 (COX-2) inhibitor which is majorly indicated in the treatment of inflammatory disorders such as rheumatoid arthritis, osteoarthritis and gout. Etoricoxib selectively inhibits COX-2 thereby inhibiting the conversion of arachidonic acid to prostaglandins (PG’s). Stevens–Johnson Syndrome (SJS) is a rare, life threatening hypersensitivity reaction that predominantly affects skin and mucous membrane which is characterised by extensive epidermal necrosis. Some of the medications which are associated with the development of Stevens Johnson syndrome include xanthine oxidase inhibitors such as allopurinol, antiepileptic medications such as carbamazepine, lamotrigine, phenytoin and Non-Steroidal Anti-Inflammatory Drugs (NSAID’s). In this case report, we summarize regarding a patient who developed SJS after usage of etoricoxib that was managed by cessation of the offending agent and symptomatic treatment concomitant with supportive care.

Key words: Cyclo-Oxygenase enzyme-2 (COX-2), Prostaglandins (PGs), Hypersensitivity, Necrosis, Non- Steroidal Anti-Inflammatory Drugs (NSAID’s).


The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmacy Practice (IJOPP) [ISSN-0974-8326] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 2008.


IJOPP uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2014 are being assigned DOIs for its permanent URLs